| Gene symbol | BCL2L12 | Synonyms | None | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.33 | dbXrefs | |
| Description | BCL2 like 12 | ||||
| GTO ID | GTC0353 |
| Trial ID | NCT03020017 |
| Disease | Gliosarcoma |
| Altered gene | BCL2L12 |
| Therapeutic/Target gene | Target gene |
| Therapy | siRNA |
| Treatment | NU-0129 |
| Co-treatment | Laboratory Biomarker Analysis|Pharmacological Study |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Phase 0 First-In-Human Study Using NU-0129: A Spherical Nucleic Acid (SNA) Gold Nanoparticle Targeting BCL2L12 in Recurrent Glioblastoma Multiforme or Gliosarcoma Patients |
| Year | 2017 |
| Country | United States |
| Company sponsor | Northwestern University |
| Other ID(s) | NU 16C01|STU00203790|P30CA060553|NCI-2016-02007 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||||
|
|||||||||||||